Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maspero

Showing results (521-530 of 536) with videos related to

Pageof 54
Sort By:
Nature Medicine|January 12, 2026
Interpretable inflammation landscape of circulating immune cellsLaura Jiménez-Gracia, Davide Maspero, Sergio Aguilar-Fernández, et al.
Nature Medicine|January 26, 2026
Publisher Correction: Interpretable inflammation landscape of circulating immune cellsLaura Jiménez-Gracia, Davide Maspero, Sergio Aguilar-Fernández, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 28, 2026
Development and validation of the Risk of Exacerbation in Severe Asthma (RESA) modelWenjia Chen, Tae Yoon Lee, David Price, et al.
International Journal of Cancer|January 6, 2010
Cancer incidence in people with AIDS in ItalyJerry Polesel, Silvia Franceschi, Barbara Suligoi, et al.
Medical Image Analysis|July 28, 2024
Generating synthetic computed tomography for radiotherapy: SynthRAD2023 challenge reportEvi M C Huijben, Maarten L Terpstra, Arthur Jr Galapon, et al.
Journal of Asthma and Allergy|October 28, 2022
Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic TherapyWenjia Chen, Mohsen Sadatsafavi, Trung N Tran, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 6, 2022
Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe AsthmaCeleste M Porsbjerg, Andrew N Menzies-Gow, Trung N Tran, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 10, 2023
Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma RegistryWenjia Chen, Trung N Tran, Mohsen Sadatsafavi, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 9, 2024
Reply to "Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry"Wenjia Chen, Trung N Tran, Mohsen Sadatsafavi, et al.
Allergy|March 17, 2023
Comparative effectiveness of anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for bothPaul E Pfeffer, Nasloon Ali, Ruth Murray, et al.
Pageof 54

Showing results (521-530 of 536) with videos related to

Sort By:
Pageof 54
Nature Medicine|January 12, 2026
Interpretable inflammation landscape of circulating immune cellsLaura Jiménez-Gracia, Davide Maspero, Sergio Aguilar-Fernández, et al.
Nature Medicine|January 26, 2026
Publisher Correction: Interpretable inflammation landscape of circulating immune cellsLaura Jiménez-Gracia, Davide Maspero, Sergio Aguilar-Fernández, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 28, 2026
Development and validation of the Risk of Exacerbation in Severe Asthma (RESA) modelWenjia Chen, Tae Yoon Lee, David Price, et al.
International Journal of Cancer|January 6, 2010
Cancer incidence in people with AIDS in ItalyJerry Polesel, Silvia Franceschi, Barbara Suligoi, et al.
Medical Image Analysis|July 28, 2024
Generating synthetic computed tomography for radiotherapy: SynthRAD2023 challenge reportEvi M C Huijben, Maarten L Terpstra, Arthur Jr Galapon, et al.
Journal of Asthma and Allergy|October 28, 2022
Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic TherapyWenjia Chen, Mohsen Sadatsafavi, Trung N Tran, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 6, 2022
Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe AsthmaCeleste M Porsbjerg, Andrew N Menzies-Gow, Trung N Tran, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 10, 2023
Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma RegistryWenjia Chen, Trung N Tran, Mohsen Sadatsafavi, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 9, 2024
Reply to "Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry"Wenjia Chen, Trung N Tran, Mohsen Sadatsafavi, et al.
Allergy|March 17, 2023
Comparative effectiveness of anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for bothPaul E Pfeffer, Nasloon Ali, Ruth Murray, et al.
Pageof 54